Cell-based Vaccines and Immunotherapy

The vaccine research program of Reliance Life Sciences is focused on developing Dendritic Cell based vaccines against cancer and chronic infections and on identifying novel immunoadjuvants and delivery systems for enhancing vaccine efficacy. These include:

• Cell based vaccines
  
• Immunomodulators

The Cell based vaccine research program of Reliance Life Sciences is aimed at developing a platform technology for ex-vivo differentiation and maturation of Dendritic cells from peripheral blood monocytes for immunotherapy of cancer and chronic infections.

The discovery research group is involved in identification, chemical synthesis and screening of novel immunomodulators derived from natural products for enhancing vaccine efficacy and for treatment of inflammatory / immune-mediated diseases.